Welcome to the Trial Talks podcast – a thought-provoking series surrounding clinical trial research. We’ll be exploring current and future trends of the ever-changing clinical trial landscape as we discuss a variety of topics including virtual trials, patient centricity, novel and unique research, pandemic impact, and more. Join us and our expert guests on a journey through the evolution of clinical trials.
All content for Trial Talks is the property of Medrio and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to the Trial Talks podcast – a thought-provoking series surrounding clinical trial research. We’ll be exploring current and future trends of the ever-changing clinical trial landscape as we discuss a variety of topics including virtual trials, patient centricity, novel and unique research, pandemic impact, and more. Join us and our expert guests on a journey through the evolution of clinical trials.
Data Visualization - Making Data Comprehensible for Early Intervention
Trial Talks
21 minutes 23 seconds
5 years ago
Data Visualization - Making Data Comprehensible for Early Intervention
Phastar and Medrio have been partnering together on trials for the past 3 years, culminating in a unique way to visualize clinical trial data. Through the use of Medrio’s API, Phastar has built a data visualization tool that reduces risk and allows for complete study oversight. In this podcast we’ll discuss the need for data visualization in clinical trials, how Phastar has continued their trials during a global pandemic, and what their thoughts are on the future of how we collect and view data.
Trial Talks
Welcome to the Trial Talks podcast – a thought-provoking series surrounding clinical trial research. We’ll be exploring current and future trends of the ever-changing clinical trial landscape as we discuss a variety of topics including virtual trials, patient centricity, novel and unique research, pandemic impact, and more. Join us and our expert guests on a journey through the evolution of clinical trials.
